FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2497153907> ?p ?o ?g. }

• W2497153907 endingPage "607" @default.
• W2497153907 startingPage "607" @default.
• W2497153907 abstract "Abstract Down Syndrome (DS) (Trisomy 21 – T21) is a common constitutional aneuploidy. Neonates and children with DS have a 150-fold increased risk of developing Acute Myeloid Leukaemia (DS-ML), characterized by a differentiation arrest of immature megakaryocyte-erythroid cells. In virtually all DS-ML patients, somatic mutations in the gene encoding the megakaryocyte-erythroid transcription factor GATA1 are acquired during fetal life leading to the production of a N-terminal truncated form of the GATA1 protein (GATA1s). We, and others, have previously shown that this N-terminal domain is necessary to prevent excessive megakaryocytic proliferation. However, the mechanisms by which GATA1, but not GATA1s, restrains megakaryocytes proliferation are unclear. To gain mechanistic insight, we generated knock-in murine ES cell models expressing biotinylated forms of either full length GATA1 or GATA1s protein. We established large scale in vitro differentiation assays to interrogate embryonic-fetal megakaryocyte differentiation (adapted from Nishikii et al., 2008. J Exp Med; 205 (8) : 1917-27; Figure 1) to define the normal megakaryocytic differentiation pathway in GATA1-expressing cells. ES cells were differentiated into embryoid bodies (EB), which were disaggregated at D6 and CD41+c-kit+ cells were cultured on OP9 feeder layers with TPO, IL6 and IL11. Detailed examination of the differentiation kinetics of populations including FACS-sorting of specific populations followed by reculture, showed complex differentiation pathways as wild type cells differentiated into both megakaryocyte and non-megakaryocyte fates. By contrast, GATA1s-expressing cells principally differentiated into megakaryocyte fate. In addition, as immature CD41+ haemopoietic cells differentiate into the megakaryocyte lineage they lose c-kit expression and CD41 expression increases (Figure 2). In the GATA1s-expressing cells compared to GATA1-expressing cells, there is marked accumulation (5 to 10-fold) of a specific immature megakaryocyte CD41++c-kit+ population that is partially blocked in differentiation (Gate R6). Cell cycle analysis shows an increase in cells in S-phase specifically in this population in GATA1s-expressing cells compared to normal cells (44% vs 27%) together with a decrease in apoptosis (5% vs 11%). To determine GATA1s direct and indirect target genes, we performed ChIP-sequencing and RNA-sequencing. RNA-sequencing of GATA1- and GATA1s-expressing CD41+ populations at D12 showed around 4500 differentially expressed genes (at a p-value of 0.05). Given the differences in cell cycle, it is noteworthy that cyclin D3 and cdk6 were expressed 1.7-fold and 1.5-fold higher in GATA1s- expressing cells. Chromatin in cis-regulatory regions of both genes was bound by GATA1 and GATA1s. Chemical inhibition of the Cyclin D3:Cdk4/6 complex reduced proliferation and induced partial differentiation of mutant cells, suggesting a role of this complex in regulating GATA1s-induced proliferation and differentiation inhibition. Knock-down and overexpression experiments to further test the role of Cyclin D:Cdk4/6 complex in both wild-type and mutant cells are in progress. Taken together, these results suggest that GATA1s alters cell cycle at a specific stage in megakaryocyte differentiation causing partial differentiation arrest and that this is mediated by altered expression and function of a Cyclin D3:Cdk4/6 complex. These results may have more general implications of how mutant transcription factors cause differentiation arrest in leukemia. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare." @default.
• W2497153907 created "2016-08-23" @default.
• W2497153907 creator A5013741325 @default.
• W2497153907 creator A5030937847 @default.
• W2497153907 creator A5039349041 @default.
• W2497153907 creator A5051182162 @default.
• W2497153907 creator A5067808997 @default.
• W2497153907 creator A5075397421 @default.
• W2497153907 creator A5084377115 @default.
• W2497153907 date "2014-12-06" @default.
• W2497153907 modified "2023-09-27" @default.
• W2497153907 title "Cellular and Molecular Basis of Mutant Haemopoietic Transcription Factor GATA1s" @default.
• W2497153907 doi "https://doi.org/10.1182/blood.v124.21.607.607" @default.
• W2497153907 hasPublicationYear "2014" @default.
• W2497153907 type Work @default.
• W2497153907 sameAs 2497153907 @default.
• W2497153907 citedByCount "0" @default.
• W2497153907 crossrefType "journal-article" @default.
• W2497153907 hasAuthorship W2497153907A5013741325 @default.
• W2497153907 hasAuthorship W2497153907A5030937847 @default.
• W2497153907 hasAuthorship W2497153907A5039349041 @default.
• W2497153907 hasAuthorship W2497153907A5051182162 @default.
• W2497153907 hasAuthorship W2497153907A5067808997 @default.
• W2497153907 hasAuthorship W2497153907A5075397421 @default.
• W2497153907 hasAuthorship W2497153907A5084377115 @default.
• W2497153907 hasConcept C104317684 @default.
• W2497153907 hasConcept C109159458 @default.
• W2497153907 hasConcept C148738053 @default.
• W2497153907 hasConcept C153911025 @default.
• W2497153907 hasConcept C192196715 @default.
• W2497153907 hasConcept C203014093 @default.
• W2497153907 hasConcept C2779282312 @default.
• W2497153907 hasConcept C2779705218 @default.
• W2497153907 hasConcept C28328180 @default.
• W2497153907 hasConcept C502942594 @default.
• W2497153907 hasConcept C54355233 @default.
• W2497153907 hasConcept C86803240 @default.
• W2497153907 hasConcept C95444343 @default.
• W2497153907 hasConceptScore W2497153907C104317684 @default.
• W2497153907 hasConceptScore W2497153907C109159458 @default.
• W2497153907 hasConceptScore W2497153907C148738053 @default.
• W2497153907 hasConceptScore W2497153907C153911025 @default.
• W2497153907 hasConceptScore W2497153907C192196715 @default.
• W2497153907 hasConceptScore W2497153907C203014093 @default.
• W2497153907 hasConceptScore W2497153907C2779282312 @default.
• W2497153907 hasConceptScore W2497153907C2779705218 @default.
• W2497153907 hasConceptScore W2497153907C28328180 @default.
• W2497153907 hasConceptScore W2497153907C502942594 @default.
• W2497153907 hasConceptScore W2497153907C54355233 @default.
• W2497153907 hasConceptScore W2497153907C86803240 @default.
• W2497153907 hasConceptScore W2497153907C95444343 @default.
• W2497153907 hasIssue "21" @default.
• W2497153907 hasLocation W24971539071 @default.
• W2497153907 hasOpenAccess W2497153907 @default.
• W2497153907 hasPrimaryLocation W24971539071 @default.
• W2497153907 hasRelatedWork W1823105344 @default.
• W2497153907 hasRelatedWork W197013897 @default.
• W2497153907 hasRelatedWork W2001026744 @default.
• W2497153907 hasRelatedWork W2041177276 @default.
• W2497153907 hasRelatedWork W2063636969 @default.
• W2497153907 hasRelatedWork W2116574829 @default.
• W2497153907 hasRelatedWork W2134907482 @default.
• W2497153907 hasRelatedWork W2153764250 @default.
• W2497153907 hasRelatedWork W2164616937 @default.
• W2497153907 hasRelatedWork W2264211064 @default.
• W2497153907 hasRelatedWork W2290826747 @default.
• W2497153907 hasRelatedWork W2550820586 @default.
• W2497153907 hasRelatedWork W2577852663 @default.
• W2497153907 hasRelatedWork W2579581480 @default.
• W2497153907 hasRelatedWork W266396228 @default.
• W2497153907 hasRelatedWork W2784361888 @default.
• W2497153907 hasRelatedWork W2978395504 @default.
• W2497153907 hasRelatedWork W2993179841 @default.
• W2497153907 hasRelatedWork W2994306245 @default.
• W2497153907 hasRelatedWork W3171712245 @default.
• W2497153907 hasVolume "124" @default.
• W2497153907 isParatext "false" @default.
• W2497153907 isRetracted "false" @default.
• W2497153907 magId "2497153907" @default.
• W2497153907 workType "article" @default.